(Press-News.org) Two-thirds of patients discontinued their medication, switched to a different medication class or intensified their treatment
Discontinuation was higher (50%) among GLP-1 RA drugs, which are linked to gastrointestinal side effects
Findings could have implications for patients taking GLP-1 RAs to treat obesity
First large U.S. study to show such high discontinuation rates
CHICAGO --- Most patients with Type 2 diabetes will end up needing to add a second-line medication after metformin — the go-to primary drug for glucose management — to control their blood sugar levels. But adherence to these second-line drugs can be hit or miss, reports a new Northwestern Medicine study.
When patients discontinue their medication, switch to a different drug or intensify their treatment (either via an increased dose, adding a third medication or starting insulin), it wastes the doctor and patient’s time, costs the health system unnecessary expense and, in the case of discontinuation, can result in a patient not fully treating their Type 2 diabetes.
The study will be published Dec. 12 in the American Journal of Managed Care.
The study of more than 82,000 patients between 2014 and 2017 found that within one year of their initial prescription, nearly two-thirds of patients either discontinued their medication, switched to a different medication class or intensified their treatment.
The scientists analyzed five non-insulin classes of diabetes medications. In four of the five classes, 38% of patients discontinued their medication. But among patients prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs), half (50%) discontinued treatment.
“Discontinuation is bad. It is common in all five types of medications, but we see significantly more in those prescribed the GLP-1 RAs,” said corresponding author David Liss, research associate professor of general internal medicine at Northwestern University Feinberg School of Medicine.
“Presumably, the doctor is saying, ‘You need to start a new medication to control your Type 2 diabetes,’ and then within a year, half of them just stop and don’t start another one, and that’s not a good thing.”
Prior studies have shown that treatment discontinuation is common for Type 2 diabetes medications, but this is the first large American study to show such high discontinuation rates in second-line medications, Liss said.
“Our findings highlight the need for new prescribing approaches and to better understand the barriers patients face when taking these medications, to ultimately reduce wasting patients’ time, clinicians’ time and the health system’s money,” Liss said.
Association with gastrointestinal side effects
While the scientists did not have data on reasons why patients discontinued treatment, the particularly high discontinuation rate for GLP-1 RAs may have been due to adverse gastrointestinal side effects — such as nausea, vomiting and diarrhea — which have been observed in patients who take these medications for diabetes control and for weight loss, Liss said.
Originally approved by the U.S. Food and Drug Administration (FDA) for treating Type 2 diabetes, GLP-1 RAs (with brand names like Ozempic and Wegovy) are now used for weight loss, too. “We know there are gastrointestinal side effects for these drugs that are currently in the news, both for patients with diabetes and patients attempting to lose weight,” Liss said.
What happens after discontinuation?
For many patients in this study, discontinuing a second-line diabetes medication wouldn’t immediately lead to hyperglycemia (high blood sugar) symptoms or medical emergencies, Liss said.
“But discontinuation still puts these patients at greater risk for downstream hospitalizations related to diabetes,” Liss added.
Endocrinologist versus internal medicine prescribers
Discontinuation risk was lower and intensification risk was higher when an endocrinologist prescribed the medication, compared to when a family medicine or internal medicine physician prescribed the second-line drugs, the study found. Liss said this difference could be because endocrinologists had particular expertise in the newer classes of diabetes drugs, enhancing their ability to discuss the pros and cons of medications when making prescribing decisions with patients.
Importance of follow-ups on new drugs
The study retrospectively analyzed patients’ health insurance claims data, meaning the scientists could identify when a patient had been prescribed a medication; if the care provider switched their medication to a new class; or if they increased their dose.
The scientists assumed that patients who experienced a treatment switch or intensification did so after talking with their doctor. But the scientists suspect that many patients made the decision to discontinue their medication without having talked to a doctor.
“Our results may represent a ‘wake-up call’ for clinicians that many of their patients were not taking the medicines that were prescribed,” Liss said. “While we don't know if providers were aware of the discontinuation events observed in this study, our results highlight the need for ongoing communication between patients and prescribers over time — around medication benefits, side effects and costs — not just at the time of prescribing.”
Other Northwestern study authors include Dr. Matthew O’Brien, Cassandra Aikman, Dr. Amisha Wallia, Andrew Cooper and Dr. Ronald Ackermann.
Funding for the study was provided by a grant from the UnitedHealth Group, which also gave the researchers access to the claims data analyzed in the study.
END
Waltham — December 7, 2023 —
At discharge from the hospital, Black Medicare beneficiaries are less likely to be referred for home health care (HHC), compared to white patients reports a survey study in Medical Care. The journal is published in the Lippincott portfolio by Wolters Kluwer.
The disparity in referral for HHC among Black Medicare patients appears greatest among those with low "readiness for discharge" scores, according to the new research, led by Olga Yakusheva, PhD, of University of Michigan School of Nursing and School of Public Health.
Does ...
BOSTON, December 12, 2023 — NEJM Group, publisher of the New England Journal of Medicine, today announced the launch of its newest title, NEJM AI, a peer-reviewed, monthly journal dedicated to the latest research and application of artificial intelligence (AI) and machine learning in medicine. In addition to original research articles, the journal publishes reviews, policy perspectives and educational material for clinicians, scientists, health care leaders, policy makers, regulators, and executives with pharmaceutical, device-manufacturing and technology companies. Benchmark data sets and protocols are ...
In addition to being one of the largest, most diverse metropolitan areas in the world with a population of 6.1 million, South Florida hosts more than 9.7 million acres of farmland with a revenue of more than $7 billion in recent years. However, climate change, extreme weather events, poor soils, pests and disease, and workforce shortages present unique challenges in this region.
To address a critical need to train a diverse workforce with new sets of tools and skills to confront these emerging challenges, ...
The Centre for Addiction and Mental Health (CAMH), Canada’s largest mental health teaching hospital in the country is pleased to announce that it has entered into a partnership with the Tanenbaum Open Science Institute (TOSI) at McGill University’s The Neuro, joining a growing alliance Canadian institutions changing research practices in neuroscience. This important endeavour is supported by a $1M commitment from the Tanenbaum Open Science Institute and an equivalent commitment by CAMH.
As part of its commitment to Open Science, CAMH is formally adopting a set of Open Science Principles to foster collaboration and the sharing of mental health ...
PHILADELPHIA— For thousands of people around the world waiting for a kidney, paired exchange serves as a beacon of hope. One person's willingness to undergo the act of Kidney Paired Donation (KPD) often sets in motion a chain of beautiful and selfless acts, where individuals give and receive the chance for a better life. After completing its 100th KPD transplant in a 12 month period, the Penn Transplant Institute now holds the world-wide record for the most KPD transplants in a year.
More than 90,000 people in the United States are waiting to receive a kidney transplant, with average waits to receive a kidney from a deceased donor ...
University of Virginia School of Medicine researchers have created an “atlas of atherosclerosis” that reveals, at the level of individual cells, critical processes responsible for forming the harmful plaque buildup that causes heart attacks, strokes and coronary artery disease.
Atherosclerosis, or hardening of the arteries, affects half of Americans between ages 45 and 84, and many don’t even know it, the National Institutes of Health reports. Over time, fatty plaques build up inside the arteries, where they can slow blood flow. When they break loose, they can be deadly, triggering strokes and heart attacks.
Doctors ...
In a Perspective, researchers call for equity in cannabis research as the field rapidly expands. When marijuana was illegal across the United States, enforcement and penalties were disproportionately heaped upon communities of color. Today, cannabis remains federally illegal and unequal enforcement continues, while profits from the “green rush” of state legalization are in many cases flowing to wealthy white men. Renée Martin-Willett and an interdisciplinary team of colleagues propose a way forward for cannabis research that acknowledges this history of discrimination and misuse of institutional power and embraces ...
During the all-out invasion of Ukraine, Russia has deliberately chosen civilian targets, such as apartment buildings, presumably with the goal of deterring Ukrainian resistance. But does such terror deter or, in contrast, motivate resistance among ordinary Ukrainians? Henrikas Bartusevičius and colleagues conducted two-wave probability surveys in Ukraine in March and April 2022, with approximately 1,000 and 800 respondents in the first and second waves, respectively. Surveys were conducted online by a local survey agency, Info Sapiens. Respondents reported the frequency of ...
When a severe drought hit California in 1977, the state ordered citizens to drastically reduce domestic water usage. Water restrictions put in place occurred after a heady mix of prosperity and radical urban planning had resulted in the construction of more than 150,000 private swimming pools in California in the 1960s. The result was a ubiquitous new landscape feature: empty concrete pools. Ulf Büntgen and colleagues document how this novel geographic resource inspired surfers to develop professional vertical skateboarding in Los Angeles and environs. Other causal factors included the development of polyurethane ...
Why did professional skateboarding arise in southern California in the 1970s? Was it a coincidence, or was it a perfect storm of multiple factors?
It’s fairly well-known that a drought in southern California in the mid-1970s led to a ban on filling backyard swimming pools, and these empty pools became playgrounds for freestyle skateboarders in the greater Los Angeles area. But a new cross-disciplinary study from the University of Cambridge shows that beyond the drought, it was the entanglement of environmental, economic and technological factors that led to the explosive rise of professional skateboarding culture in the 1970s.
The authors say that professional ...
